Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeartburn is one of the more commonly reported side effects of Mounjaro (tirzepatide). It tends to appear in the first few weeks of treatment, or after a dose increase, and for most people it settles on its own. The slowing of gastric emptying that makes Mounjaro effective for weight management also means stomach acid can sit against the lower oesophagus for longer — that is the mechanical reason behind the discomfort. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before any treatment begins, and any persistent or severe symptoms should be discussed with your clinical team rather than managed alone. The NHS tirzepatide patient information page lists gastrointestinal effects including indigestion and reflux as common during treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first thing worth knowing is that heartburn on Mounjaro tends to cluster around two moments: the very beginning of treatment and the days following a dose increase. Tirzepatide slows the rate at which the stomach empties into the small intestine. That delay is useful (it prolongs the feeling of fullness and helps regulate blood sugar) but it also keeps acidic stomach contents close to the lower oesophageal sphincter for longer than usual. When that sphincter relaxes slightly, acid moves upward and the familiar burning sensation behind the breastbone follows.
This is not a sign that something has gone wrong. It is the predictable result of how the medicine interacts with your digestive system. The episodes are usually at their worst in the first two weeks after starting 2.5mg or after each subsequent step up, then ease as your body adjusts to the new dose level. Keep a quick mental note of when the burning tends to happen (before or after meals, lying down at night, or after coffee) because that one-minute check tells you a great deal about which practical change will make the biggest difference.
For a broader overview of what to expect across the digestive side-effect profile, the full Mounjaro side effects guide covers nausea, constipation and other GI effects in the same framework.
Most heartburn on tirzepatide responds well to a handful of straightforward adjustments, and many people find they need only one or two of them. Eating smaller, more frequent meals reduces the volume of food pressing against the lower sphincter at any one time, a logical fit with the reduced appetite Mounjaro tends to produce anyway. Waiting at least two to three hours before lying down after your last meal of the day removes one of the most common triggers for night-time reflux.
Fatty and fried foods slow gastric emptying further on top of Mounjaro's own effect, so they can amplify the problem noticeably. The same applies to carbonated drinks, caffeine and alcohol, all of which relax the oesophageal sphincter independently. Raising the head of your bed by a few centimetres (or using an extra pillow) can reduce nocturnal symptoms without any dietary change at all.
Over-the-counter antacids are widely used for occasional reflux, but before reaching for them regularly, check with your prescriber or pharmacist. Some antacids can affect the absorption timing of other medicines, and your clinical team may have a preferred approach given your full medication picture. Never self-escalate to proton pump inhibitors without clinical input.
If you are thinking about the broader treatment and cost landscape, our Mounjaro treatment overview explains what a private prescription pathway involves from consultation through to aftercare.
Mild, intermittent acid reflux that responds to the steps above is common and manageable. There are circumstances, though, where symptoms need proper clinical review rather than self-management.
If heartburn is severe, worsening rather than settling, or is accompanied by difficulty swallowing, persistent nausea, or vomiting that does not ease within a day or two of a dose increase, contact your prescriber. The same applies if you are finding it hard to eat or drink adequately, prolonged poor intake can lead to dehydration and nutritional shortfalls, neither of which should be pushed through alone.
One symptom pattern that must not be attributed to ordinary reflux: severe, persistent stomach pain that radiates toward the back, with or without vomiting. The MHRA's Yellow Card reporting scheme documents acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, and a Drug Safety Update issued in January 2026 reinforced that this symptom pattern warrants urgent medical assessment, not a wait-and-see approach. Heartburn does not typically radiate to the back; pain that does should be treated as a different concern entirely.
Patients who have a history of gastro-oesophageal reflux disease (GORD) or a hiatus hernia should flag this during their consultation, since these conditions can be aggravated by delayed gastric emptying and may need proactive management rather than a reactive approach.
Questions about cardiac-related symptoms that can sometimes be confused with reflux are covered separately on the Mounjaro and heart side effects page.
Heartburn rarely arrives entirely alone on Mounjaro. It often appears alongside nausea, burping, or a general sense of fullness that lingers longer than expected. The GI side-effect cluster tends to be dose-dependent (lighter at 2.5mg, more noticeable as the dose increases toward 10mg or 15mg) which is one reason the titration schedule exists. The gradual progression is not arbitrary; it gives the gastrointestinal system time to adapt at each level.
If the combination of side effects is making treatment feel unsustainable, that conversation belongs with your prescriber, not with an online forum. Pausing at a dose rather than escalating, or adjusting the timing of the injection relative to meals, are options a clinician can consider. Stopping abruptly or switching medicines without guidance is not advisable.
The dedicated heartburn and tirzepatide resource goes deeper on the clinical evidence around GI management strategies during GLP-1 treatment. And if you have seen questions about whether Mounjaro causes heartburn or worsens existing reflux, that question has its own detailed answer drawing on the same clinical data.
At the end of treatment, some people want to understand what happens to side effects as the medicine clears the system. The Mounjaro face side effects page addresses one of the more widely searched post-treatment concerns and links onward to the broader recovery picture.
If you are already on treatment and finding heartburn difficult to manage, or if you are considering starting and want to understand the full side-effect profile before committing, speaking with our clinical team is the most direct route to a personalised answer. Speak to our prescribers through a free consultation, a real clinician reads your assessment the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.